Aethlon Medical Inc Market cap
What is the Market cap of Aethlon Medical Inc?
The Market cap of Aethlon Medical Inc is $4.08M
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Industrials sector on NASDAQ compared to Aethlon Medical Inc
What does Aethlon Medical Inc do?
the aethlon medical (nasdaq:aemd) mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. our aethlon adapt™ platform provides the technology foundation for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. the aethlon adapt™ product pipeline includes the hemopurifier®, a first-in-class medical device with broad-spectrum capabilities against exosomes that contribute to the progression of cancer and infectious viral pathogens such as hiv and hepatitis c.
Companies with market cap similar to Aethlon Medical Inc
- Prime Dividend has Market cap of $4.07M
- Aquila European Renewables Income Fund has Market cap of $4.07M
- International Montoro Resources has Market cap of $4.07M
- Mercantile Ports & Logistics has Market cap of $4.08M
- Polyfair has Market cap of $4.08M
- California Software has Market cap of $4.08M
- Aethlon Medical Inc has Market cap of $4.08M
- Constellation Technologies has Market cap of $4.08M
- Alianza Minerals has Market cap of $4.09M
- Allied Healthcare Product has Market cap of $4.09M
- Sahara Housingfina has Market cap of $4.10M
- Durango Resources has Market cap of $4.10M
- Stanrose Mafatlal Investments and Finance has Market cap of $4.11M